ESTHER COHEN: Open Payments
NPI 1255417242 · REISTERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,372 in 138 payments from 18 companies in 2025. Trend: 2023 $2,338 · 2024 $3,629 · 2025 $3,372
Food & beverage: $3,232Education: $140
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 19 | $486 |
| UCB, Inc. | 19 | $476 |
| ABBVIE INC. | 12 | $367 |
| GENZYME CORPORATION | 10 | $335 |
| Regeneron Healthcare Solutions, Inc. | 8 | $250 |
| Organon LLC | 9 | $236 |
| Janssen Biotech, Inc. | 17 | $233 |
| Amgen Inc. | 5 | $213 |
| Novartis Pharmaceuticals Corporation | 11 | $182 |
| Lilly USA, LLC | 6 | $137 |
Products named: DUPIXENT, Bimzelx, ADBRY, SKYRIZI, TREMFYA, OTEZLA, COSENTYX, VTAMA.
Industry payments across MD — which companies pay providers there.
